Home

Woad

We wanted to develop certain products for body care that takes into account changed habits and natural environment's issues, we wanted products largely natural and that contains a special herbal active ingredient. In the course of our research, we discovered a plant whose nurturing and healing effects played an important role even before the turn of the century: we call it WOAD or WAID.

Its oily or alcoholic-aqueous extract has a favorable dermatological and nourishing effect, making it available for cosmetic preparations. The waid plant grows in Thuringia on a purely organic basis, the extracts are produced particularly using non-polluting and clean processes.

Woad is also the name of a blue dye produced from the leaves of the plant, the plant is native to the steppe and desert zones of the Caucasus, Central Asia to eastern Siberia and Western Asia but is now also found in southeastern and Central Europe and western North America. The plants have already received great attention from the Assyrians, Babylonians, Greeks and Romans for their healing properties. Later, they were used by Hildegard von Bingen and Paracelsus in the art of healing.

The plant has been cultivated since antiquity as a colorant. In Germany, the dyer's woad is cultivated since the 9th century, mainly in Thuringia. Special mills, Waidmühlen, were required for its processing. Dyer's woad was very important for the production of blue linen until about the 16th century. Blue Indigo dyes were once rare. A large percentage of indigo dye produced today – several thousand tons each year – is on the other hand completely synthetic.

But the applications don't stop to the cosmetics and to colorants, there are other areas of interests. Because of the wood protection effect (inhibited fungal growth), Woad is also suitable for painting doors, ceiling and interiors. A real revival took place at the end of the 1980s in Thuringia, when research revealed new fields of application. Woad is totally biodegradable and safe in the environment.

Products specs

Waidplant

The Waidplant is also known as "dyer's waid" (Isatis tinctoria L.), "Pastel" or "German indigo". This plant has its origin in Western Asia and presently increases mainly as ferns in Europe.

The dried leaves have been used for blue coloring, for wood preservation (stunted fungus growth) and the roots as therapeutic principles to relieve pain and fever in patients suffering from influenza (A, B) infections.

Waidsubstances

The biological basis for the planned products originated from two different and unique biochemical substances, the active chemical compounds of the Waidplant and additional materials from the sector of the cationic surfactants & esters also found in the Waidplant.

Surfactants

Surfactants are emulsifying compounds which reduce the surface tension of water and aqueous dispersions and are able to transfer oils into aqueous dispersions and suspensions. ISATIL^® has also the potential exhibiting various surface activities, even in very dilute suspensions (liquid-solid). These materials reveal strong antimicrobial, antibacterial and antifungal activities in addition to their anticorrosive characteristics.

Cationic surfactants (Cationic lipid, CL) and vaccine on lipid A basis

Another product line contains the development of cationic N and/or P-surfactants (lipids, CL), those are completely biologically biodegradable and at the ecological test system level are classified as harmless.

Other products include the development and later commercialization of enantiomers of the aryl propionic acids in new pharmaceutical inactive ingredients; chiral salts and adducts with S-metlyladenosine, also as anti-viral components and as a dietary supplement, and as cationic N and/or P-surfactant which are completely biologically biodegradable and at the ecological test system level are classified as harmless. The further development of natural vaccines (AUTOVACCINE) on the basis of non- endotoxic Lipid A-diphosphates and their derivates from non-endotoxic Gram- negative E. coli strains, faecalis and or salmonella.

Quaternary Phosphonium-combinations show similar acute & chronic toxicities as quaternatry N-surfactants but enhanced anti-microbial (50x) and antiviral activities. The development of cationic (N&P) surfactants have led inter alia to long-lasting active substances against methicillin-resistent Staphylokokken strains when administrating pharmaceutically resistant antibiotics (E. coli, Ps. Aer.) strains.

An outstanding effectivley new role of the cationic surfactants is its quality against enveloped or not enveloped viruses as well as Picorna viruses in vitro (animal experiments, e.g. purification and/or germ-free attitude of the cage). This applies also to aggressive saccharomyces albicans populationen of the Candida type and in general against viruses of the Influenza type A & B. An exponentiation effect can be achieved through complexation with specified zinc salts.

However, the development of dipolar ionic N- or P cationic surfactants and suitable combinations with the benzethonium types (cell cultures) enhances the antiviral and antmicrobial effectiveness but ensures also long-lasting effects. This is possible by adding or complexing suitable antineoplastic compounds to the dipolar ionic N-or P- surfactants or CL, respectively (nonane-adenosine surfactants). This would possible enlighten new possibilities not only for CT-diagnostic but also against local and circumscribed appearances in the case of neurodermititis and allergic (dermatological) appearances.

Cationic lipids (CL) are not only known for their applications in the transfer of genetic material, pharmaceutical formulations (Galenik), in cleaning processes (domestic homes, office rooms, hospitals etc.) but also in the material sciences (spongy materials). The polar-non polar surfaces at the membrane play a significant role for the interaction with the DNA, proteins and other biopolymers and/or pharmaceutical ingredients.

Our target is to study the effects of small structural changes close to the cationic head group of a lipid on the adsorbed water side by simply e.g. Brewster- Angle-Microscopy and X-ray scattering or diffraction technology in combination with molecular dynamic simulations (MD).

The MD-simulations should support and complement the final conclusions from the experiments via the molecular structure of the lipids including their influence of the water (ions, multifunctional & active molecules) and the influence of the counterions. The works should lead to a better description of the water-ion reciprocal actions and to a better understanding of the Hofmeister-rule.

Furthermore, other potential new applications of the cationic surfactants should result from their antimicrobial, bioremediation and antibacterial effects: bactericide against Gram-positive and/or Gram-negative microbial strains, fungicide (and Candida), ambient human and veterinary protozoan-illnesses.

The associated anions (Hofmeister rule) within the context of these investigations & developments assumes the use of simple halide ions which may be inserted in the complex. The applied methods embrace in addition to the above ones Solid-State NMR spectroscopy (magic angle spinning spec), electron microscopy, Zeta-potential- measurements, isothermic titration calorimetry, confocal fluorescence microscopy.

In addition rheological properties of the investigated compounds should conclude the relevant stages as a function of the temperature, nature of counterions, of the concentration and of the pH-value in order to characterize the product. For potential applications in the pharmaceutical & chemical industry the studies are important aides to stability (stress experiments, disposition of the mass periods) of the products.

About us

Presentation of the Enterprise

Wert Pharma-Laboratories Enterprise is a limited liability corporation and will manufacture and distribute antimicrobial, antibacterial and antiviral products produced from purely biological substances found in the Waidplant. The product has been developed, planed and executed by Prof Dr. rer. nat, Dr. med., MD Henrich Hasko Paradies, PhD (h.c.), Dr. Sci (h.c.), FRSC & CC.

The product ISATIL^® is purely based on biological compounds Furthermore, the following products are in the development:

• - Hygiene surfactants for the household & cleaning industry;
• - Corrosion reduction and counter-measures for the steel- & petroleum industry
• - Active and inactive pharmaceutical ingredients for the chemical industry according to the state of art;
• - Developments of surface-active materials from ISATIL^® with applications in the metal- and car industry;

In order to develop and manufacture the products a close cooperation with scientific institutions (Jacobs University, Bremen, Germany; Salford University, Manchester, U.K.; University and CNRS, Montpellier, France) is scheduled offering the foremost & extensive expertise for the successful development of the products by obeying accepted standards (GCP, GMP, GcP, FDA & Eu-Pharm).

Business Plan

Foundation Idea

Some of the basic chemical compounds and their effects of the Waidplant are known for a long time but it has never been explored and in detail documented. More than 4,000 reference objects are amenable and provide a strong evidence for their endurance and protection. Prof. Paradies and his group solved this problem partially and as a part of the results obtained at Salford University, Manchester (UK) the basic principles of the various chemical compounds have been elucidated.

Important improvements of the developed substances in the Waidplant have been made with respect to amplification by the internal products and its future application possibilities e.g. that is convenient for the preservation and restoration of large buildings, wooden houses, cellars and general households. The effectiveness of the product which is sanitarily harmless and in every respect harmless to children can easily monitored by eye and sanitary measures taken by skilled personal.

Construction and Production planning

The start encompasses the construction as planned and industrial production of the material- and building-protective product ISATIL^®. The product is suitable for the preservation and restoration of buildings & concrete. The effectivness consists in the building materials to be treated and the compounds of the Waid-essence is sanitary harmless and in every respect even for children, particularly for e.g. every form of masonry or wood, into a depth of some centimetres penetrates.

The material and building protective product ISATIL^® penetrates by osmosis in lithic and wooden surfaces. The subsequent oxidation of the active substance causes a sort of drying in the walls and the substances which come in touch with the aktive ingredients of ISATIL like fungus and mold will be completely destroyed and prevented also new growth in due time.

The endurance has been proved by centuries of old water pipes of the Incas and equally well with the old Erfurter "WAID houses" which have been treated with the initial substance of the Waidessence: they still exist today in astoundingly good state. The basics substances and the effect of the now optimized and advanced one initial product of the Waidplant are known for a long time so the followingly described effectivness preserves without doubt.

Guidelines

GLP -tested after guidelines 93/21 EWG ANH.4; B4; B5 and guidelines 93/69 EWG, part C2. Subsequently it is planned to establish an industrial production of natural substances, chiral pharmaceutical active medicinal compounds with new pharmaceutical auxillaries:

1. of corrosive processes
2. long lasting Protection of building materials (Wood, general building supplies, wallpaper and so on)
3. long lasting effectiviness against microbial infestation and subsequent protection

These qualities of the Waid are also valid for metallic materials, cement and ceramic suppliers, less for synthetic where exclusively surface profiles are in treatable. Furthermore, isolation of the natural substance of the Waid contained new possible applications and needed characterization and evaluation, both in the material technical and in pharmaceutical sector (anti-inflammatory, dermatologically, anti- microbial, anti-fungal and is not based on antibiotic processes; harboring also anti- viral or similar effects with new and innovativ medical indication e.g. in the cardiovascular sector, or chronic and acute rheumatic diseases.

Other products will include the development and the marketing of

1. Cationic quaternary nitrogen (N) and/or new phosphonium (P)-surfactants ("cationic lipids") with corresponding anionic counterions. These new cationic surfactants (C-L) are biologically biodegradable and are to be classified as harmless into ecological test system.
2. Chiral salts and adducts consisting of S-methyladenosine ("active methionine", SAM), with R-alanine or R-Serine (also in complex with zinc ions), S- arginine (also in complex with manganese ²⁺), S-lysine or S-histidine as adducts with pyruvic acid.
3. with anti-viral (known) components like Aciclovir and congeners, or antisense nucleotides, planned for therapies in the anti-viral sector (topical and endemic), particularly for conditioning of herpes infections with their eroding capabilities as well as against second infections as chemical complex compounds with SAM and n-nlkyl (C₈-C₁₀)-bisphosphonic acids which are planned for treating parasitic protozoa illnesses
4. On the sector of dietary supplements it is SAM with e.g. pyruvic acid, particular salts of pyruvic acid (zinc & calcium) to mention, the enantiomers (R & S) of the thioct acid (lipoic acid) for the use in conditioning diabetes type 2, the rheumatic diseases (inflammations) has to be mentioned, in addition to a complex with biopterin as radical inhibitor.
5. Newly complexes existingly from the pharmacological acting active compounds of the aryl propionic acids e.g. with enantiomeren S-(+)-ibuprofen with SAM or meglumine-descendants.

A further development in a sense of anionic surfactants exists in natural vaccines (AUTOVACCINE) on the basis of non-endotoxic lipid A-diphosphates and their derivates (with cationic surfactants) obtained from non-toxic Gram-negative E.coli strains, faecalis and or salmonella, respectively.

Unique Selling Proposition ISATIL^® (USP)

The Unique Selling Proposition of the Product ISATIL^® consists here in the kind of production to deliver this for centuries basically known natural product, it avoided the previous commercialization technic problems, existed on the extremely odor development and in a cloudy coloring.

The effectiveness consists in the treated materials and attacked surfaces (e.g. every form of masonry or wood), that substance of the Waidessence is sanitary harmless and in every respect even for children, get fly up onto it into a depth of some centimeters penetrates, except that these are not sealed.

ISATIL^® is toxicologically harmless, non-polluting, biodegradable, not harmful to skin and eyes; and has received no rating as sanitary or toxicologically or harmfully substance.

Objective Target

The leading step is to develop the product ISATIL^® for readiness to start the production and to establish as a label into the relevant target audience. Within 5 years, a market position among the topics 5 providers, a market share of 5%, a sales objective of at least 700,000.00 € will be aspired, and also a break even after three years. It will be achieved a very high safety and environmental standards in order to get a very good customers contentment.

The stage of development of the product ISATIL^® is so far, after carrying out of so-called stress tests (building protective product, see above) and the environmental toxicological non-objection can be start with the production end of 2019. These still outstanding tests will be done at the labs of Bremen Jacobs University as a co- partner and also carried out from outlying institutes (for the office eco-seal: Blue angel^®, Eco institute^®, the golden M^®, EC1 plus^®, nature plus^®, DGNB^®). Commercialization of the product can be started at the end of 2019.

Analysis

Analysis of the initial situation for the product ISATIL^®

The analysis refers to the the building protective product ISATIL^® itself to start with, because the other products be still in the development and the planning.

Analysis of the target audience

The target audience analysis occurs according to

1. Identify Wish/need/problem (WBP).
2. Plan a solution.
3. Appoint the target audience.

Previously, the demand for this product is already exorbitantly high. The inquiry calls at different color producers yielded a very high interest at the acceptance and commercialization of the product.

1. The product is able to eliminate the essential parts of buildings harmful influences and to preserve the building permanently. The customers, in particular large house building societies have the problem in a considerable percentage, the situation of the flat moisture which is based on erroneous ventilation, of carrying out renovation works or of ascending basement moisture.
2. The building protective product ISATIL^® can without great additional costs, preparatory works and noise pollution simple fly up onto the affected part by the consumer himself.
3. The product should be offered by the wholesale on the German market. That means it should become a business to business (B2B) business and only be sold at wholesale and/or house building societies.

Analysis of the competitors

The competitors and their products are not able to be compatible with the qualities of the protective product ISATIL^® of the Waidessence.

How many & which competitors

Many competition are on the German market, here are only mentioned the most usual ones from the building center (DIY Store) markets as for example Hellweg building center, Toom market or Hagebau center. The most usual Products which get offered there are inter alia HammeritTM, Consolean^®, Xyladecor^®, Bondex^®, Osmo^® or Renovo^®.

Offer of competitors

In the case of all competitive products are large preparatory works by eliminating from plaster or excavation soil necessary. This increases the additional costs and it is combined with considerable inconveniences for the inhabitants through noise and dirt. In addition all artificially compounds are produced of chemically materials.

Margin sizes, sq., price of competitors

The competitive products are offered at packaging sizes of 0,125 milliliter up to 25 Liter and a price margin per liters offered from 12,50 € to 21,32 €.

Initial analysis for the product ISATIL^®

For the building protective product ISATIL^® is already a market segment with building supplies at the market available. The Unique Selling Proposition of the product ISATIL^® must be very much emphasized from the start.

Previously the demand for this product is already exorbitantly high. The inquiry calls at different color producers yielded a very high interest at the acceptance. For the products who will be still developed are market segments (Pharma-, steal/Petro- and cleaning industry) also available at the market.

Spreadsheets

SWOT Analysis

SWOT ANALYSIS

Internal criterion →	Strength	Weakness
External criterion ↓
Opportunities	know How in research & development/management nonpolluting products holder of letters patent & license product program planning grand interest quality assurance through University	access to new customers
Threats	amount of potential buyers	availableness of the renewably raw matierial existent market /segment amount of competitors

The chances for the product ISATIL^® on the worldwide market exist, there are needs for it and risks are minimal.

Financial planning

FINANCIAL PLANNING

Start

End

31.3.2019

30.6.2019

30.9.2019

31.12.2019

31.3.2020

30.6.2020

31.9.2020

31.12.2020

Products

Quarter

Year

Quarter

Year

1

2

3

4

1

2

3

4

building protective (ISATIL)

4

2019

open

x

x

x

x

x

cationic surfactants

2

2020

open

x

x

x

dietary supplements

4

2020

open

x

vaccines

4

2021

open

ibuprofen

start after licence

antiviral appliances

start after licence

Start

End

31.3.2021

30.6.2021

30.9.2021

31.12.2021

31.3.2022

30.6.2022

31.9.2022

31.12.2022

Products

Quarter

Year

Quarter

Year

1

2

3

4

1

2

3

4

building protective (ISATIL)

4

2019

open

x

x

x

x

x

x

x

x

cationic surfactants

2

2020

open

x

x

x

x

x

x

x

x

dietary supplements

4

2020

open

x

x

x

x

x

x

x

x

vaccines

4

2021

open

x

x

x

x

x

ibuprofen

start after licence

antiviral appliances

start after licence

Capital requirements planning

CAPITAL REQUIREMENTS

Capital requirements planning	rounding 18 months	4 years	Notes
Start up costs
capital stock	25.000,00 €	25.000,00 €	lump payment
registration of corporations, notary	1.000,00 €	1.000,00 €	lump payment
registration licences/fees	30.000,00 €	30.000,00 €	lump payment
Summary start up costs	56.000,00 €	56.000,00 €
Investment for production of goods & services
property/building (renting starts in year 2 )
renovation & building costs			still open
equipment/manufacturing facility	781.000,00 €	781.000,00 €	still open
planned maintanace/servicing	22.500,00 €	60.000,00 €	lump payment
Summary investment	853.500,00 €	941.000,00 €
Business expenses at the founding state
material- & magazinestock (Waid for 20.000l/p.a.)	30.000,00 €	80.000,00 €
auxiliary & working material (e.g. office supplies)	10.500,00 €	28.000,00 €	acceptance
external labor (tax counselor)	10.500,00 €	28.000,00 €	acceptance
labor costs	390.000,00 €	1.373.000,00 €
marketing	20.000,00 €	12.000,00 €
material costs for research & development	22.500,00 €	60.000,00 €	acceptance
patent& licence fees	45.000,00 €	60.000,00 €
capital surplus for special expense	5.000,00 €	5.000,00	acceptance
others	5.000,00 €	5.000,00	acceptance
Summary business expenses	538.500,00 €	1.651.000,00 €
Financing
short/medium-term financing trade accounts	7.500,00 €	20.000,00 €	acceptance
medium-term bond (interest rate and amortization	45.000,00 €	182.920,00 €	Bank KfW 180
Summary financing	52.500,00 €	202.920,00 €
Summary capital investments	1.500.500,00 €	2.850.920,00 €

Financial planning B

FINANCIAL PLANNING B

Equity capital	capital stock	25.000,00 €
	equity capital	621.000,00 €
	open shareholding
	workers shareholding
	others
	Summary equity capital	646.000,00 €
Tier 3 capital	shareholder loan
	subordinated loan
	dormant equity holding with subordination clause
	enterprise resource planning (ERP) capital
	other
	Summary tier 3 capital
Committed assets	bank loan (long-term)	500.000,00 €
	bank loan (medium-term)
	current accounts loan
	supplier credit
	dormant equity holding
	offical government-funded loan
	other
	Summary commited assets	500.000,00 €
Other financial instruments	profits
	allowances, subsidy	250.000,00 €
	other cash inflow
	Summary other financial instruments	250.000,00 €
Total cash inflow		1.396.000,00 €
Financing needs		1.396.000,00 €
Debit balance/deficient cover

Investment planning

investment year	2019	2020	2021	2022
Property & building
property
building
new & reorganization
Summary property & building
Administrative department
office furniture
automobile
telephones, fax
IT (Hard-ware & Software)	2.977,00 €
other
Summary administrative department	2.977,00 €
Research and development
laboratory equipment	469.098,00 €
IT (Hardware & Software)	38.446,00 €
other
Summary research & development	507.544,00 €
Production
machines	270.000,00 €
other
Summary production	270.000,00 €
Total amount of investment	780.521,00 €

Profit planning

PROFIT PLANNING

	2019				2020
Products	Sales volume	Unit	Prize	Profit	Sales volume	Unit	Prize	Profit
building protective (ISATIL)		liter	34,42 €		10.000	1 liter	34,42 €	344.239,33 €
catonic surfactants
dietray supplements
vaccines
ibuprofen
antiviral appliance
Summary profit								344.239,33 €
	2021				2022
Products	sales volume	unit	prize	profit	Sales volume	Unit	Prize	Profit
building protective (ISATIL)	20.000	liter	34,42 €	688.478,66 €	30.000	liter	34,42 €	1.032.717,99 €
catonic surfactants
dietray supplements
vaccines
ibuprofen
antiviral appliance
Summary profit				688.478,66 €				1.032.717,99 €

Curriculum Vitae Herr Henrich H. Paradies

Hasko Henrich Paradies, German chemistry professor, consultant. Achievements include over 200 patents in field. Fellow Royal Society Chemistry (England); member American College of Surgeons, American Materials Research Society, American Neutron Scatter Society, New York Academy of Sciences, Charles Darwin Association, Gesellschaft Deutsche Naturforscher und Arzte.

Doctor of Philosophy in Biochemistry (honorary), Albert Einstein-Foundation, 1990. Diploma chemistry, Doctor of Medicine, University Munster, 1966. Doctor of Philosophy in Medicine, University Munster, 1967.

Postgraduate, University Munster, 1970. Doctor of Philosophy in Chemistry, University Uppsaa, 1969. Postgraduate, King's College, 1971.

Postgraduate, Massachusetts Institute of Technology, 1971. Doctor in Bio-chemical Science (honorary), Royal Crown Spain, 1986.

Career

Research associate University Munster, 1966. Postdoctoral fellow King's College, 1969-1971, Boston, 1971-1972. Research associate Max Planck Institute, Berlin, 1971.

Professor biochemistry Free University Berlin, 1974-1983, chairman department chemistry and biochemistry, 1974-1977, chairman department plant physiology and cell biology, 1980-1982. Professor biotechnology and physical chemistry University Applied Sciences, since 1988. Faculty chemistry and chemical engineering University Paderborn, 1997—2000.

Professor University Salford, Manchester, England, since 2000. Guest and visiting professor chemistry Cornell University, Ithaca, New York, 1977—1979. Director research and development Medice-Corporation, Ltd., 1984—1986, director, since 1986.

Senior lecturer technical chemistry department engineering University Hagen, 1985—1986. Science consultant, counsel Sherex, Inc., Dublin, Witco, Inc., Greenwich, Connecticut, Medice, Inc., Germany, Octapharma, Germany, SKW AG, Symbiopharm. Guest professor biotechnology and physical chemistry Märkische Hochschule Iserlohn, University Applied Sciences, 1987—1988.

Chaired professor biotechnology and physical chemistry University Paderborn, since 1997. Visiting professor Louisiana State University, 1991—1993. Visiting professor chemistry department Ohio State University, since 1992.

Visiting professor Materials Science Center, Joule Physics Laboratory, Salford University, Manchester, England, 2000—2001. Research-visiting professor Institute Materials Science, Salford University, Manchester, England, 2001—2006. Distinguished visiting professor Joule physics laboratory University Salford, Manchester, England, since 2006.

Fellow Royal Society Chemistry (England). Member American College of Surgeons, American Materials Research Society, American Neutron Scatter Society, New York Academy of Sciences, Charles Darwin Association, Gesellschaft Deutsche Naturforscher und Arzte.

Curriculum Vitae Frans-Maurits Verbruggen

Education and training

Partner Frans Verbruggen has a wide expertise in Diamonds, Mineralogy and Business-Managment. He studied in Lier, Gewestelijke Technische School for Diamond and in Technisch Institute Borgerhout-Antwerpen. From '75 to '77 he was working in Förderungswerk Köningstein, under the supervision of the University of Mainz, dependence Idar-Oberstein, Germany. Between 1978-1979 he was at REFA (rational & efficiency working & production organizing), then in IHK (Chamber for Industry and Business) in Mönchengladbach, Germany. From 1979 to 1980 he was Education Tutor for technical skills, for IHK.

From 1960 to 1970, in Cologne Germany, he was busy as goldsmith, gemstone setter & polisher, watchmaker, working in the sector of bookkeeping and business-management. In the nineties he studied at Janssen-Pharmaceutics & with the Chamber of Commerce, in Beerse-Turnhout. Some years after, during 2001 and 2003 he was mining in Venezuela, Brazil & Mozambique. In Prato, Italy, in 2006 he worked as a salesrepresentant for industrial wood- & leather furniture, and as a insurance broker at Dela & General in 2007. Went on until 2010 in administration and managing in the real estate field: buying & selling, notarial contracts, and translations.

He speaks Dutch, incl. South African, German, including Schweitzer Deutsch, English, French, Italian, basic Spanish, passive Portuguese & Romanian.

Practical experiences

From 1960 to 2002 he was an independent entrepreneur working with his own staff producing and selling diamonds, gemstones and jewelry for different jewelry shops and gemological institutes. He was also an educator in jewelry and gemstone craftsmanship & expertise.

During 1978-1979 he was one of the partecipators of a German mission to introduce a gemological institute in Colombo/Sri Lanka. From '87 to '97 he was a partner in a wholesale company of luxury and silver jewelry in Leuven, Mol and in Moscow, Russia. Then until 2002 in Udapradesh, New Delhi, India, while being busy as tutor in Koningstein, Germany.

In the nineties he was tutoring in Moscow, reorganizing jewelry factories in India, from 2000 to 2006, and he was a partner in precious metals raffination plant in Antwerp. He was also engaged in Administration and Governance of real estate in Germany; from 2007 to 2017. He was occupied in consultancy for Indian, Italian and Belgian companies for mining and reorganization, joint-venture in jewelry & precious metals in Antwerp, Cologne, Moscow, India, Italy and Turkey.

Labo's Staff

The Biochemical Faculty members from the Jacobs University in Bremen will take care of the Laboratory and of the production. This team will change according to the internal development work; it's difficult to nominate at the moment the laboratory's technicians in charge.

Contact